Science 37 Holdings Inc   (SNCE)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


Science 37 Holdings Inc

SNCE's Financial Statements and Analysis

Science 37 Holdings Inc reported II. Quarter net loss per share of $-0.05 compare to earnings per share of $0.00 in the same quarter a year ago a decrease from $0.35 eps realized in I. Quarter (Mar 31 2022).

II. Quarter
Earnings Per Share Revenues
$ -0.05 $  19 Mill
$-0.05     $+19M    

Science 37 Holdings Inc 's Revenue rose by 0 % in II. Quarter (Jun 30 2022) year on year, to $19 million and advanced by 3.15 % sequentially.

Science 37 Holdings Inc is Expected to report next financial results on May 08, 2023.

More on SNCE's Income Statement

Science 37 Holdings Inc 's in II. Quarter recorded net loss of $-11.666 million, an increase from net loss of $-0.105 million in III. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $89.787 million in previous quarter.

More on SNCE's Growth

Science 37 Holdings Inc Inventories
In II. Quarter company's net cash and cash equivalents decreased by $-18 million, capital expenditures fell by